Collaboration Agreements - Biogen (Details) - USD ($) |
3 Months Ended | 9 Months Ended | 72 Months Ended | |||
|---|---|---|---|---|---|---|
Sep. 30, 2026 |
Sep. 30, 2025 |
Sep. 30, 2026 |
Sep. 30, 2025 |
Sep. 30, 2026 |
Dec. 31, 2025 |
|
| Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items] | ||||||
| Total collaboration revenue | $ 17,778,000 | $ 0 | $ 21,382,000 | $ 0 | ||
| Biogen | Collaborative Arrangement | ||||||
| Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items] | ||||||
| Remaining performance obligation | 0 | 0 | $ 0 | $ 0 | ||
| Contract liability | $ 0 | $ 0 | 0 | $ 0 | ||
| Biogen | Biogen Collaborative Arrangement | Product | ||||||
| Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items] | ||||||
| Total collaboration revenue | 0 | |||||
| Biogen | Biogen Collaborative Arrangement | Milestone Triggered | ||||||
| Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items] | ||||||
| Total collaboration revenue | $ 0 | |||||
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of transaction price allocated to performance obligation that has not been recognized as revenue. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|